Somnus Technologies creates ultra‑minimally invasive, mask‑free airway therapies for snoring and mild‑to‑moderate obstructive sleep apnea. Its HYPNARA™ palatal implant reinforces the soft palate in a brief office procedure, while MORPHEX™AI combines a smart oral device with AI‑driven detection of snoring, airway events, and potential concussive impacts, offering clinicians real‑time analytics without the need for nightly masks or surgery.
Funding
Funding not disclosed
Founders
Product
Problem
Snoring and obstructive sleep apnea affect millions, causing fragmented sleep, relationship strain, and heightened health risks. Existing treatments often rely on uncomfortable masks, invasive surgeries, or weight‑loss medications that do not directly stabilize the upper airway.
Solution
Somnus Technologies develops ultra‑minimally invasive, mask‑free airway therapies that reinforce the soft palate and monitor breathing without external devices. The HYPNARA™ system is an office‑based palatal implant that mechanically supports the airway to reduce snoring and mild‑to‑moderate OSA. MORPHEX™AI combines a smart oral appliance with AI algorithms to detect snoring, airway events, and potential concussive impacts in youth sports, providing real‑time analytics for clinicians and patients. Both solutions are engineered for simple in‑office placement, eliminating the need for nightly masks or extensive surgical procedures, and aim to restore natural breathing from the inside out.
Target Audience
Primary customers are sleep‑medicine clinicians and otolaryngologists seeking minimally invasive, mask‑free options for patients with snoring or mild‑to‑moderate obstructive sleep apnea, as well as sports medicine programs monitoring youth athletes for breathing‑related injuries.
Features
- HYPNARA™: minimally invasive palatal implant placed in a brief office procedure to reinforce the soft palate
- MORPHEX™AI: smart oral device equipped with sensors and AI‑driven detection of snore patterns and airway events
- AI analytics platform that flags abnormal breathing events and potential concussive impacts in real time
- Mask‑free design eliminates nightly equipment discomfort and improves patient adherence
- Office‑based deployment enables clinicians to offer treatment without operating‑room resources
- Transparent pricing model focused on patient‑first affordability